# Dose Escalation Safety Study of MM-10-001 in Healthy Subjects

> **NCT00677027** · PHASE1 · UNKNOWN · sponsor: **GlycaNova Norge AS** · enrollment: 50 (estimated)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** lentinan
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00677027
- **Lead sponsor:** GlycaNova Norge AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677027, "Dose Escalation Safety Study of MM-10-001 in Healthy Subjects". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00677027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*